M
Massimo Donadelli
Researcher at University of Verona
Publications - 96
Citations - 10208
Massimo Donadelli is an academic researcher from University of Verona. The author has contributed to research in topics: Cancer cell & Cancer. The author has an hindex of 35, co-authored 89 publications receiving 8125 citations. Previous affiliations of Massimo Donadelli include Vision-Sciences, Inc. & Academy of Sciences of the Czech Republic.
Papers
More filters
Journal ArticleDOI
Regulation of succinate dehydrogenase and role of succinate in cancer
Elisa Dalla Pozza,Ilaria Dando,Raffaella Pacchiana,Elio Liboi,Maria Teresa Scupoli,Massimo Donadelli,Marta Palmieri +6 more
TL;DR: An extensive examination of the role of succinate in cancer development through the induction of epigenetic and metabolic alterations and the effects on epithelial to mesenchymal transition, cell migration and invasion, and angiogenesis is reported.
Journal ArticleDOI
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells
Ilaria Dando,Claudia Fiorini,Elisa Dalla Pozza,Chiara Padroni,Chiara Costanzo,Marta Palmieri,Massimo Donadelli +6 more
TL;DR: It is demonstrated for the first time that UCP2 plays a role in autophagy regulation bringing new insights into mitochondrial uncoupling protein field.
Journal ArticleDOI
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway.
Edoardo Missiaglia,Massimo Donadelli,Marta Palmieri,Tatjana Crnogorac-Jurcevic,Aldo Scarpa,Nicholas R. Lemoine +5 more
TL;DR: Investigation of changes in global gene expression observed after treatment of different pancreatic cancer cell lines with the methylase inhibitor 5-aza-2′-deoxycytidine found increased p21WAF1 and gadd45A expression to be associated with the efficacy of the treatment and induction of interferon-related genes may correlate with activation of the IFN signalling pathway.
Journal ArticleDOI
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation
Paolo Piacentini,Massimo Donadelli,Chiara Costanzo,Patrick S. Moore,Marta Palmieri,Aldo Scarpa +5 more
TL;DR: It is demonstrated that TSA can effectively increase the drug sensitivity of all the cell lines studied and may represent an experimental basis for potential clinical application of HDAC inhibitors, in particular in association with drugs used in cancer clinical treatment, supporting the idea thatHDAC inhibitors could act as sensitizers for chemotherapy.
Journal ArticleDOI
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells.
Patrick S. Moore,Stefano Barbi,Massimo Donadelli,Chiara Costanzo,Claudio Bassi,Marta Palmieri,Aldo Scarpa +6 more
TL;DR: One prominent feature was the increased ratio between the levels of expression of pro-APoptotic and anti-apoptotic genes, which was confirmed in eight additional pancreatic cancer cell lines after treatment with TSA, suggesting that this event may be a strong determinant for the induction of apoptosis by TSA.